Archive · 24 Aug 2026
Aptus Pharma Plans Rs 45 Crore Raise and Expansion
Aptus Pharma wants to collect Rs 45 crore to grow its business.
The plan must first be approved by shareholders and regulators.
The company says it may use the money over 36 months after receiving it.
It wants to make some of its products in its own factories.
Its goal is to produce about 20 per cent of its needs itself.
This could help the company manage quality, supplies and product availability.
Aptus Pharma also wants to sell its products in more parts of India.
It is considering business opportunities in Africa, the Middle East and Latin America.
These overseas plans will depend on market conditions, regulations and whether they make commercial sense.
Aptus Pharma plans to raise Rs 45 crore through a preferential issue.
The fundraising requires shareholder approval at the Annual General Meeting on September 14, 2026, along with other regulatory clearances.
The company aims to eventually manufacture about 20 per cent of its product requirements in-house.
Aptus Pharma plans to expand its domestic sales and distribution network toward a Pan-India presence.
The company is exploring opportunities in Africa, the Middle East and Latin America through registrations, exports and partnerships.
- Who
- Aptus Pharma.
- What
- Aptus Pharma plans to raise Rs 45 crore, increase in-house manufacturing and expand its domestic and international operations.
- When
- The shareholder vote is scheduled for September 14, 2026; proceeds are proposed to be used within 36 months of receipt.
- Where
- The company plans to expand across West, Central, East and South India and explore Africa, the Middle East and Latin America.
- Why
- To strengthen manufacturing, quality control, supply-chain management, product availability, brand development and market expansion.
- Planned fundraising
- Rs 45 crore through a preferential issue
- Shareholder approval
- Annual General Meeting scheduled for September 14, 2026
- Use of proceeds
- Proposed to be utilised within 36 months of receiving the funds
- Manufacturing target
- Eventually meet around 20 per cent of product requirements through in-house manufacturing
- Domestic expansion
- Strengthen sales and distribution across West, Central, East and South India
- International markets
- Africa, the Middle East and Latin America
- Expansion conditions
- Commercial viability, market conditions and regulatory approvals